Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 4;185(16):2899-2917.e31.
doi: 10.1016/j.cell.2022.06.054. Epub 2022 Jul 31.

Glioblastoma hijacks neuronal mechanisms for brain invasion

Affiliations
Free article

Glioblastoma hijacks neuronal mechanisms for brain invasion

Varun Venkataramani et al. Cell. .
Free article

Abstract

Glioblastomas are incurable tumors infiltrating the brain. A subpopulation of glioblastoma cells forms a functional and therapy-resistant tumor cell network interconnected by tumor microtubes (TMs). Other subpopulations appear unconnected, and their biological role remains unclear. Here, we demonstrate that whole-brain colonization is fueled by glioblastoma cells that lack connections with other tumor cells and astrocytes yet receive synaptic input from neurons. This subpopulation corresponds to neuronal and neural-progenitor-like tumor cell states, as defined by single-cell transcriptomics, both in mouse models and in the human disease. Tumor cell invasion resembled neuronal migration mechanisms and adopted a Lévy-like movement pattern of probing the environment. Neuronal activity induced complex calcium signals in glioblastoma cells followed by the de novo formation of TMs and increased invasion speed. Collectively, superimposing molecular and functional single-cell data revealed that neuronal mechanisms govern glioblastoma cell invasion on multiple levels. This explains how glioblastoma's dissemination and cellular heterogeneity are closely interlinked.

Keywords: cancer neuroscience; cell heterogeneity; glioblastoma; glutamatergic synapse; neurogliomal synapses; neuron-tumor interaction; tumor cell networks; tumor microtubes.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests F.W. and W.W. report the patent (WO2017020982A1) “Agents for use in the treatment of glioma.” F.W. is co-founder of DC Europa Ltd (a company trading under the name Divide & Conquer) that is developing new medicines for the treatment of glioma. Divide & Conquer also provides research funding to F.W.’s lab under a research collaboration agreement.

Comment in

Similar articles

  • Tweety-Homolog 1 Drives Brain Colonization of Gliomas.
    Jung E, Osswald M, Blaes J, Wiestler B, Sahm F, Schmenger T, Solecki G, Deumelandt K, Kurz FT, Xie R, Weil S, Heil O, Thomé C, Gömmel M, Syed M, Häring P, Huber PE, Heiland S, Platten M, von Deimling A, Wick W, Winkler F. Jung E, et al. J Neurosci. 2017 Jul 19;37(29):6837-6850. doi: 10.1523/JNEUROSCI.3532-16.2017. Epub 2017 Jun 12. J Neurosci. 2017. PMID: 28607172 Free PMC article.
  • Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression.
    Ratliff M, Karimian-Jazi K, Hoffmann DC, Rauschenbach L, Simon M, Hai L, Mandelbaum H, Schubert MC, Kessler T, Uhlig S, Dominguez Azorin D, Jung E, Osswald M, Solecki G, Maros ME, Venkataramani V, Glas M, Etminan N, Scheffler B, Wick W, Winkler F. Ratliff M, et al. Neuro Oncol. 2023 Dec 8;25(12):2150-2162. doi: 10.1093/neuonc/noad109. Neuro Oncol. 2023. PMID: 37335907 Free PMC article.
  • [Glioblastomas exploit neuronal properties: a key to new forms of treatment?].
    Venkataramani V, Winkler F. Venkataramani V, et al. Nervenarzt. 2024 Feb;95(2):96-103. doi: 10.1007/s00115-023-01589-y. Epub 2023 Dec 29. Nervenarzt. 2024. PMID: 38157044 Review. German.
  • Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing.
    Tetzlaff SK, Reyhan E, Layer N, Bengtson CP, Heuer A, Schroers J, Faymonville AJ, Langeroudi AP, Drewa N, Keifert E, Wagner J, Soyka SJ, Schubert MC, Sivapalan N, Pramatarov RL, Buchert V, Wageringel T, Grabis E, Wißmann N, Alhalabi OT, Botz M, Bojcevski J, Campos J, Boztepe B, Scheck JG, Conic SH, Puschhof MC, Villa G, Drexler R, Zghaibeh Y, Hausmann F, Hänzelmann S, Karreman MA, Kurz FT, Schröter M, Thier M, Suwala AK, Forsberg-Nilsson K, Acuna C, Saez-Rodriguez J, Abdollahi A, Sahm F, Breckwoldt MO, Suchorska B, Ricklefs FL, Heiland DH, Venkataramani V. Tetzlaff SK, et al. Cell. 2025 Jan 23;188(2):390-411.e36. doi: 10.1016/j.cell.2024.11.002. Epub 2024 Dec 6. Cell. 2025. PMID: 39644898
  • Neuronal signatures in cancer.
    Jung E, Alfonso J, Monyer H, Wick W, Winkler F. Jung E, et al. Int J Cancer. 2020 Dec 15;147(12):3281-3291. doi: 10.1002/ijc.33138. Epub 2020 Jun 19. Int J Cancer. 2020. PMID: 32510582 Review.

Cited by

Publication types